Arias, H.R. 1998. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochimica et Biophysica Acta (BBA) 1376: 173-220.
Beirami, E., Oryan, S., Valizadegan, F. & Zarrindast, M. 2012. Performance evaluation of interference morphine and β-Adrenergic system of dorasal hippocampus on anxiety-related behaviour in male wistar rat. Journal of Mazandaran University of Medical Science 22: 50-59.
Bergles, D.E., Doze, V.A., Madison, D.V. & Smith, S.J. 1996. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. Journal of Neuroscience 16: 572-585.
Bowery, N.G., Bettler, B., Froestl, W., Gallagher, J.P., Marshall, F., Raiteri, M. & Enna, S.J. 2002. International union of pharmacology. XXXIII. Mammalian γ-aminobutyricacidB receptors: structure and function. Pharmacological Reviews 54: 247-264.
Camps, M., Kelly, P.H. & Palacios, J.M. 1990. Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species. Journal of Neural Transmission/General Section JNT 80: 105-127.
Carobrez, A.P & Bertoglio, L.J. 2005. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neuroscience & Biobehavioral Reviews 1: 1193-1205.
Cheetham, S.C., Crompton, M.R., & Katona. C.L. 1988. Brain GABAA/ benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Research 460: 114-123.
Chen, N. & Justice, J.B. 2000. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine. Molecular Brain Research 75: 208-215.
Davis, M. & Whalen, P.J. 2001. The amygdala: vigilance and emotion. Molecular Psychiatry 6: 13-34.
Engin, E. & Treit, D. 2007. The role of hippocampus in anxiety: intracerebral infusion studies. Behavioral Pharmacology 18: 365-374.
Frolund, B., Ebert, B., Kristiansen, U., Liljefors, T. & Krogsgaard-Larsen, P. 2002. GABA-A receptor ligands and their therapeutic potentials. Current Topics in Medicinal Chemistry 2: 817-832.
Gholaminejad, A., Naghdi, N. & Soleimannejad, E. 2008. Interaction between testosterone and bicuculline GABAA antagonist in the CA1 region of hippocampus in spatial learning in adult male rats. International Journal of Endocrinology & Metabolism 4: 215-225.
Izquierdo, I. & Dias, R.D. 1983. Effect of ACTH, epinephrine, β-endorphin, naloxone, and of the combination of naloxone or β-endorphin with ACTH or epinephrine on memory consolidation. Psychoneuroendocrinology 8: 81-87.
Jafari-Sabet, M. 2011. Involvement of dorsal hippocampal muscarinic cholinergic receptors on muscimol state-dependent memory of passive avoidance in mice. Life Sciences 88: 1136-1141.
Johnston, G.A. 2013. Advantages of an antagonist: bicuculline and other GABA antagonists. British Journal of Pharmacology 169: 328-336.
Kabuto, H., Yokoi, I., Iwaya, K. & Mori, A. 1995. Monoamine release in the rat striatum is induced by 8-guanidinovaleric acid and inhibited by GABA agonists. Life Sciences 56: 1741-1748.
Luft, T., Pereira, G. S., Cammarota, M. & Izquierdo, I. 2004. Different time course for the memory facilitating effect of bicuculline in hippocampus, entorhinal cortex, and posterior parietal cortex of rats. Neurobiology of Learning and Memory 82: 52-56.
Lydiard, R.B. 2003. The role of GABA in anxiety disorders. Journal of Clin Psychiatry 64: 21-27.
Matsumoto, M., Yoshioka, M., Togashi, H., Hirokami, M., Tochihara, M., Ikeda, T. & Saito, H. 1994. Mu-opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis. Brain Research 636: 1-8.
Matsumoto, R.R. 1989. GABA receptors: Are cellular differences reflected in function? Brain Research Review 14: 203-225.
Mccabe, B.J., Horn, G. & Kendrick, K.M. 2001. GABA, taurine and learning: Release of amino acids from slices of chick brain following filial imprinting. Neuroscience 105: 317- 324.
Mereu, G., Yoon, K.W.P., Boi, V., Gessa, G.L., Naes, L. & Westfall, T.C. 1987. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. European Journal of Pharmacology 141: 395-399.
Nestler, E.J., Hyman, S.E. & Malenka, R.C. 2001. Molecular neuropharmacology: a foundation for clinical neuroscience. McGraw-Hill Medical 4: 779-780.
Paxinos, G., & Watson, C. 2006. The rat brain in stereotaxic coordinates: hard cover edition. Elsevier, p: 17.
Piri, M., Navaeian, M. & Pakpour, B. 2014. Assessment of effects of α2-Adrenoceptor agonists and antagonists in dorsal hippocampus on Muscimol State-dependent memory. Qom University of Medical Science Journal 1: 16-26.
Qi, X.L., Zhu, B., Zhang, X.H. & Li, B.M. 2008. Are β-adrenergic receptors in the hippocampal CA1 region required for retrieval of contextual fear memory? Biochemical and Biophysical Research Communications 368: 186-191.
Rezayof, A., Razavi, S., Haeri-Rohani, A., Rassouli, Y. & Zarrindast, M.R. 2007. GABA A receptors of hippocampal CA1 regions are involved in the acquisition and expression of morphine-induced place preference. European Neuropsychopharmacology 17: 24-31.
Sasaki, K., Fan, L.W., Tien, L.T., Ma, T., Loh, H.H. & Ho, K. 2002. The interaction of morphine and γ-aminobutyric acid (GABA) ergic systems in anxiolytic behavior: using μ-opioid receptor knockout mice. Brain Research Bulletin 57: 689-694.
Scheiderer, C.L., Dobrunz, L.E. & McMahon, L.L. 2004. Novel form of long-term synaptic depression in rat hippocampus induced by activation of α1 adrenergic receptors. Journal of Neurophysiology 91: 1071-1077.
Shulz, D.E., Sosnik, R., Ego, V., Haidarliu, S. & Ahissar, E. 2000. A neuronal analogue of state-dependent learning. Nature 403: 549-553.
Squire, L.R., & Knowlton, B.J. 2000. The medial temporal lobe, the hippocampus, and the memory systems of the brain. The New Cognitive Neurosciences 2: 756-776.
Tayebi Meybodi, K., Vakili Zarch, A., Zarrindast, M.R. & Djahanguiri, B. 2005. Effects of ultra-low doses of morphine, naloxone and ethanol on morphine state-dependent memory of passive avoidance in mice. Behavioral Pharmacology 16: 139-145.
Tsuda, M., Suzuki, T., Misawa, M. & Nagase, H. 1996. Involvement of the opioid system in the anxiolytic effect of diazepam in mice. European Journal of Pharmacology 307: 7-14.
Turgay, A. 2009. Psychopharmacological treatment of oppositional defiant disorder. CNS Drugs 23: 1-17.
Yan, Q.S. 1999. Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis. European Journal of Pharmacology 385: 7-13.
Zakharenko, S.S., Patterson, S.L., Dragatsis, I., Zeitlin, S.O., Siegelbaum, S.A., Kandel, E.R. & Morozov, A. 2003. Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses. Neuron 39: 975-990.
Zarrabian, S., Farahizadeh, M., Nasehi, M. & Zarrindast, M.R. 2016. The role of CA3 GABAA receptors on anxiolytic-like behaviors and avoidance memory deficit induced by NMDA receptor antagonists. Journal of Psychopharmacology 30: 215-223.
Zarrindast, M.R., Rostami, P., Zarei, M. & Roohbakhsh, A., 2005. Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated Plus-maze in rats. Basic and Clinical Pharmacology and Toxicology 97: 276-281.